CORRESP

0001193125-22-179044.txt : 20220726 0001193125-22-179044.hdr.sgml : 20220726 20220622215300 ACCESSION NUMBER: 0001193125-22-179044 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20220622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc. CENTRAL INDEX KEY: 0001907685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 617.871.2101 EXT 313 MAIL ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 CORRESP 1 filename1.htm CORRESP

Comera Life Sciences Holdings, Inc.

12 Gill Street

Suite 4650

Woburn, Massachusetts 01801

Tel: (617) 871-2101

June 22, 2022

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Alan Campbell

Re:	Comera Life Sciences Holdings, Inc.

Registration Statement on Form S-1

File No. 333-264686

Dear Mr. Campbell:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the registrant Comera Life Sciences Holdings, Inc. hereby requests acceleration of effectiveness of the above-referenced Registration Statement so that it will become effective at 4:00 p.m. ET on Friday, June 24, 2022, or as soon as practicable thereafter.

Very truly yours,

COMERA LIFE SCIENCES HOLDINGS, INC.

Jeffrey S. Hackman

Chief Executive Officer

cc:	Loeb & Loeb LLP

•

Mitchell S. Nussbaum, Esq.

•

Janeane R. Ferrari, Esq.

GRAPHIC 2 g619951g65t11.jpg GRAPHIC begin 644 g619951g65t11.jpg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